After encountering unspecified problems, NASA said late Nov. 10 that controllers were able to deploy the solar array on the JPSS-2 satellite after launch. Credit: NOAA WASHINGTON — A weather satellite ...
Vorasidenib becomes the first targeted therapy for grade 2 isocitrate dehydrogenase (IDH)–mutant glioma to receive FDA approval. "Today's approval of Voranigo is an enormous leap forward in cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results